Stay updated with breaking news from Chimerix inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lipella Pharmaceuticals (NASDAQ:LIPO – Get Free Report) and Chimerix (NASDAQ:CMRX – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations and earnings. Insider and Institutional Ownership 74.3% of Lipella Pharmaceuticals […] ....
StockNews.com Lowers Chimerix (NASDAQ:CMRX) to Sell dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Chimerix (NASDAQ:CMRX – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday. A number of other brokerages also recently commented on CMRX. HC Wainwright restated a “buy” rating and issued a $11.00 target price on shares of […] ....
Chimerix (NASDAQ:CMRX – Get Free Report) posted its earnings results on Wednesday. The biopharmaceutical company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.04), Zacks reports. Chimerix had a negative return on equity of 39.62% and a negative net margin of 25,337.96%. During the same quarter last […] ....
Chimerix (NASDAQ:CMRX) Issues Earnings Results theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.